Resumen
The novel coumarin-based 'turn-on' fluorescent probe (E)-3-(2,5- dimethoxybenzylideneamino)-7-hydroxy-2H-chromen-2-one (MGM) was designed, synthesized, and characterized. This compound shows high selectivity for Cu +2, combined with a large fluorescence enhancement upon binding to Cu 2+. Benesi-Hildebrand and Job plots demonstrate that the stoichiometry of the Cu 2+ complex formed is 2:1. Preliminary studies employing epifluorescence microscopy demonstrated that Cu +2 could be imaged in human neuroblastoma SH-SY5Y cells treated with MGM.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 5280-5283 |
Número de páginas | 4 |
Publicación | Tetrahedron Letters |
Volumen | 53 |
N.º | 39 |
DOI | |
Estado | Published - sep. 26 2012 |
Financiación
This work was supported by the Millennium Scientific Initiative (Grant P05-001-F) and by the Instituto Nacional de Ciência e Tecnologia do Meio Ambiente-USP (Brazil). JCNF thanks the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) for a Visiting Professor Fellowship. FHQ and LCF acknowledge fellowship support from the CNPq-Brazil.
Financiadores | Número del financiador |
---|---|
CNPq-Brazil | |
Instituto Nacional de Ciência e Tecnologia do Meio Ambiente-USP | |
Fundação de Amparo à Pesquisa do Estado de São Paulo |
ASJC Scopus Subject Areas
- Biochemistry
- Drug Discovery
- Organic Chemistry